Medication info
Crametin Tablet 375 mg (Amoxicillin-Potassium Clavulanate)

Crametin Tablet 375 mg (Amoxicillin-Potassium Clavulanate)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Korea Sintex Pharmaceutical Co., Ltd.
Appearance
This medication is a white or almost white oval film-coated tablet.
Packaging
100 tablets (10 tablets/PTP x 10)
Approval status
Active

MFDS item code 201801493 · Approved 2018.04.04

Summary

Main use
Treatment of respiratory and ear infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined according to the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Dose adjustments are based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, give an additional dose during dialysis, and repeat the dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanate are reduced).
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Korea Sintex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is effective against various bacterial infections and is used to treat respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, and lung abscesses. It also helps with upper respiratory infections such as tonsillitis, sinusitis, and otitis media. It is suitable for treating urinary tract infections such as cystitis, urethritis, and pyelonephritis, and is used in the treatment of pelvic infections and sexually transmitted infections like gonorrhea. It is effective in treating skin and soft tissue infections, boils, and abscesses, and can treat osteomyelitis and dental infections. This medication is helpful in improving a variety of infections.

How to take

Adult dose

The dose of this medicine should be determined according to the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Dose adjustments are based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, give an additional dose during dialysis, and repeat the dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanate are reduced).

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. Children: Reduce the dose in the same manner.

Precautions

This medication is a beta-lactam antibiotic and should not be used in patients with hypersensitivity to penicillin or cephalosporin drugs or a history of allergy to any ingredient in this medication. Particularly, patients with viral infections such as infectious mononucleosis or lymphocytic leukemia are at a higher risk of rash and should avoid using this medication. Patients who have experienced liver dysfunction or jaundice from this medication or penicillin-based drugs in the past should also avoid administration due to the risk of recurrence. Patients with impaired liver function should use this medication cautiously as it may worsen liver function. Patients with moderate to severe renal impairment may have prolonged retention of the medication in the body, and dosing intervals should be adjusted accordingly. Caution is needed for allergic patients or those with a family history, as symptoms such as bronchial asthma, skin rash, and urticaria may easily occur. Patients who have difficulty swallowing, the elderly, or those in poor general condition may show signs of vitamin K deficiency and should be monitored. Patients with gastrointestinal disorders experiencing severe vomiting or diarrhea may not absorb the medication properly, so caution is advised. This medication may cause gastrointestinal side effects such as diarrhea, vomiting, and abdominal pain, and serious intestinal infections such as pseudomembranous colitis may occur, so treatment should be discontinued immediately if unusual symptoms occur. Symptoms of liver dysfunction have also been reported; this is particularly more common in the elderly and males, so regular liver function tests are needed during prolonged treatment. Rarely, severe hypersensitivity reactions such as skin rash and anaphylactic shock may occur, and these should result in immediate discontinuation of use and medical attention. Blood abnormalities such as leukocytopenia and thrombocytopenia have also been reported, so monitoring through blood tests is necessary with long-term use. Central nervous system adverse reactions such as anxiety, confusion, and seizures may infrequently appear, so care must be taken if neurological symptoms arise. Women who are pregnant or may become pregnant should avoid using this medication, particularly in the first trimester, and breastfeeding women should also take care as side effects may occur in the infant. This medication is only recommended for children aged 12 and over or weighing over 40 kg, as there is insufficient experience for younger children. Elderly patients may more easily experience adverse effects due to decreased physiological function, so dosage and administration intervals should be adjusted, and their condition should be closely monitored. While taking this medication, there may be interactions with other drugs, particularly anticoagulants, probenecid, and allopurinol, and caution is warranted when taken together. Additionally, the effectiveness of oral contraceptives may decrease, so patients taking them should be aware of this. In case of overdose, symptoms such as vomiting, diarrhea, renal failure, and seizures may occur, so medical personnel should be notified immediately for appropriate treatment. Storage should be in a cool, dry place below 25 degrees Celsius to maintain efficacy.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • indigestion
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • loss of appetite
Show 78 more
  • abdominal pain
  • abdominal bloating
  • constipation
  • colonic pain
  • hyperacidity
  • loose stools
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-related colitis
  • bloody stools
  • itching
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • vesicular exfoliative dermatitis
  • acute generalized pustular dermatitis
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchial spasms
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • reversible leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphocytopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vulvar itching
  • burning sensation
  • increased secretion
  • restlessness
  • anxiety
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • seizures
  • antispasmodic
  • fever
  • altered consciousness
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • symptoms of vitamin K deficiency
  • hypoprothrombinemia
  • bleeding tendency
  • symptoms of vitamin B group deficiency
  • glossitis
  • neuritis
  • linear IgA disease
  • taste disturbance
  • lethargy
  • dermatitis
  • oral edema
  • gastric pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • decreased urine output
  • interstitial brain seizures
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a sealed container to prevent moisture and stored in a dry place below 25 degrees Celsius to maintain efficacy. Therefore, it is important to avoid direct sunlight and keep it away from humid areas.

Appearance and packaging

Appearance

This medication is a white or almost white oval film-coated tablet.

Package unit

100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.